Edwards Lifesciences Corp. will acquire micro-cap Cas Medical Systems Inc. (Casmed) for about $100 million. The pair were partnered already on 510(k) clearance-pending cable and software to connect Casmed's Fore-Sight brain tissue oxygenation monitor to Edwards' Hemosphere hemodynamic monitoring platform for surgery and critical care.